UBI adjusts stake in Shanghai Shen Lian, unfreezes shares

UNITED BIOMEDICAL, INC. (UBI) reduced its stake in Shanghai Shen Lian Biomedical Corporation from 10.52% to 10.00% through a concentrated bidding transaction between November 24 and November 28, 2025. This reduction of 2,135,400 shares, representing 0.52% of the company's total share capital, triggered a 5% integer multiple change in equity. Share prices for these transactions ranged from RMB 9.38 to RMB 9.89.

Concurrently, UBI announced the unfreezing of 1,081,221 previously frozen shares on November 27, 2025. This unfreeze represents 0.26% of the company's total share capital, bringing UBI's total unrestricted holdings to 41,064,498 shares. This action follows a series of judicial freezes and forced reductions between 2019 and March 2023.

UBI remains a significant shareholder, and the company stated these equity adjustments will not impact its controlling shareholder, actual controller, corporate governance, or daily operations. UBI plans to continue its share reduction plan, intending to divest up to an additional 3.00% of the total share capital.